First Quadrant’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Quadrant’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,100	Closed	-$584K	–	330
2021 Q4	$584K	Buy	50,100 +2,700	+6%	+$33.1K	0.06%	228
2021 Q3	$619K	Hold	47,400	–	–	0.07%	220
2021 Q2	$610K	Buy	47,400 +200	+0.4%	+$2.29K	0.07%	229
2021 Q1	$528K	Sell	47,200 -1,068	-2%	-$11.3K	0.06%	250
2020 Q4	$550K	Buy	48,268 +2,268	+5%	+$24.8K	0.05%	231
2020 Q3	$414K	Sell	46,000 -23,921	-34%	-$238K	0.05%	245
2020 Q2	$722K	Buy	69,921 +22,521	+48%	+$230K	0.1%	205
2020 Q1	$478K	Sell	47,400 -12,195	-20%	-$143K	0.07%	272
2019 Q4	$793K	Buy	59,595 +17,895	+43%	+$197K	0.07%	255
2019 Q3	$358K	Buy	+41,700	New	+$405K	0.03%	354

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Quadrant's IRWD Position: Q1 2022 in Review

First Quadrant sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2022, closing a stake of 50,100 shares — an estimated $584K sold.

First Quadrant first reported a position in IRWD in Q3 2019 and held it in 10 quarters. The position peaked at $793K in Q4 2019. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

First Quadrant reported no remaining Ironwood Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 50,100 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $584K.
First Quadrant first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 10 quarters.
First Quadrant's Ironwood Pharmaceuticals position peaked at $793K in Q4 2019.
221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.